MedPlus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, received a suspension order for a drug license for one of its stores in Telangana. The suspension is for five days and is expected to result in a potential revenue loss of Rs 2.34 lacs. The company stated this order impacts the financial operation to some extent.
Drug License Suspension in Telangana
MedPlus Health Services Limited has disclosed a significant development concerning its subsidiary, Optival Health Solutions Private Limited. The company has received a suspension order for a drug license pertaining to a store located in Hanamkonda, Telangana. This order was issued by the Assistant Director, Drugs Control Administration, Warangal.
Impact and Details of the Order
The suspension of the drug license is effective for five days. The order, received on July 30, 2026, cites violations under Rule 65 of the Drugs and Cosmetics Act, 1940, and the associated Drugs and Cosmetics Rules, 1945. MedPlus estimates a potential revenue loss of approximately Rs 2.34 lacs due to this suspension. The company has communicated that this event will have a quantifiable impact on its financial operations.
Source: BSE
